Donor-derived hepatitis C in the era of increasing intravenous drug use: A report of the Disease Transmission Advisory Committee

A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors

(2017) Pallavi D. Annambhotla et al.   Transplant Infectious Disease

Deceased Organ Donors and PHS Risk Identification

(2017) Timothy L. Pruett et al.   TRANSPLANTATION

PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Transmission through Organ Transplantation

(2017) Debbie L. Seem et al.   PUBLIC HEALTH REPORTS

Landscape of Deceased Donors Labeled Increased Risk for Disease Transmission Under New Guidelines

(2015) L. M. Kucirka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening

(2015) A. Suryaprasad et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-Derived Transmission Events in 2013

(2015) Michael Green et al.   TRANSPLANTATION

Risk of Window Period Hepatitis-C Infection in High Infectious Risk Donors: Systematic Review and Meta-Analysis

(2011) L. M. Kucirka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

An Update on Donor-Derived Disease Transmission in Organ Transplantation

(2011) M. G. Ison et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Uniform Definitions for Donor-Derived Infectious Disease Transmissions in Solid Organ Transplantation

(2011) Christian Garzoni et al.   TRANSPLANTATION

Nucleic Acid Testing (NAT) of Organ Donors: Is the ‘Best’ Test the Right Test? A Consensus Conference Report

(2010) A. Humar et al.   AMERICAN JOURNAL OF TRANSPLANTATION